EMILY WYNINGER: Open Payments
NPI 1740890367 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,110 in 114 payments from 20 companies in 2025. Trend: 2023 $582 · 2024 $1,417 · 2025 $2,110
Food & beverage: $2,098Education: $12
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $545 |
| ABBVIE INC. | 31 | $484 |
| AstraZeneca Pharmaceuticals LP | 7 | $182 |
| Lilly USA, LLC | 9 | $167 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $165 |
| Novo Nordisk Inc | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Dexcom, Inc. | 4 | $71 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Exact Sciences Corporation | 2 | $37 |
Products named: FANAPT, JARDIANCE, VRAYLAR, QULIPTA, BREZTRI, UBRELVY, CAPLYTA, Dexcom G6 Transmitter.
Industry payments across LA — which companies pay providers there.
